epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions

The clinical information you need, at your fingertips.

Medical News for You

Government Health Agency News

FDA

3h

FDA approves Rasonque, first treatment to broadly target RAS in metastatic pancreatic cancer

This oral drug blocks a key growth signal found in most pancreatic cancers and nearly doubled median survival versus chemotherapy. . .
Journal Article Synopsis

Diabetes Obes Metab

4h

Tirzepatide tied to lower healthcare costs in older adults

Costs held flat in treated adults over 55 while rising in matched untreated peers, with the difference widening over 18 months of therapy. . .
Government Health Agency News

FDA

4h

Ketone tracking joins CGM in first-of-its-kind wearable

FDA authorizes Abbott’s Libre Duo 10 Day, the first device to continuously monitor both glucose and ketone levels. . .
Government Health Agency News

FDA

5h

Imaavy becomes first FDA-approved treatment for warm autoimmune hemolytic anemia

Nipocalimab-aahu adds targeted therapy to a treatment landscape long reliant on corticosteroids and broad immunosuppression. . .

Journal Article Synopsis

Arthritis Rheumatol

5h

Real-world data sharpen concerns about avacopan

US registry data identify confirmed severe drug-induced liver injury despite a low overall rate of liver enzyme abnormalities. . .

Journal Article Synopsis

Cochrane Database Syst Rev

6h

Vapes top nicotine patches, gum for smoking cessation

An updated review found high-certainty evidence for e-cigarettes over nicotine replacement therapies when it comes to efforts to stop smoking. . .

Journal Article Synopsis

Sci Adv

6h

Blood test identifies sepsis pathogen in hours, not days

A single run returns both the organism and its drug susceptibility, a proof-of-concept result that requires validation. . .

Journal Article Synopsis

Lancet Healthy Longev

7h

Can older adults safely stop statins?

Randomized trial finds no increase in 3-year mortality after deprescribing statins used for primary prevention in adults aged 75 years and older. . .

Government Health Agency News

FDA

7h

FDA approves Ziihera regimens for first-line HER2-positive gastroesophageal cancer

The new regimens expand treatment choices, with the immunotherapy-containing option extending survival regardless of PD-L1 status. . .

Trending icon

TRENDING THIS WEEK

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information